Ali R. Khaki, MD

Ali R. Khaki, MD, of Stanford Medicine

Articles by Ali R. Khaki, MD

Neoadjuvant Pembrolizumab and aMVAC for Non-Urothelial MIBC: Does This Combination Improve Outcomes?

Petros Grivas, MD, PhDUrothelial Carcinoma | February 21, 2025

Drs. Grivas, Khaki, and Raychaudhuri discuss a phase II trial evaluating pembrolizumab plus aMVAC for non-UC MIBC.

Navigating Second-Line Treatment After EV+P: Insights from a Survey of Urothelial Cancer Experts

Priyanka V. Chablani, MDUrothelial Carcinoma | February 20, 2025

Four experts weigh in on their survey-based study of sequencing after 1L EV/pembro in the evolving landscape of la/mUC.